XML 54 R35.htm IDEA: XBRL DOCUMENT v3.25.0.1
Schedule of net deferred tax assets (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
Net operating loss carry-forward $ 4,427,679 $ 288,379
Section 174 Qualified Research Expenditures 995,500 526,248
Stock Compensation 1,680,019
R&D Credit 51,278
Other 28,007 31,724
Deferred tax assets, gross 7,182,483 846,351
Less: valuation allowance (7,182,483) (846,351)
Deferred tax assets, net
Total net deferred tax asset